These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25744393)

  • 1. Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA.
    Silva AS; Ariza D; Dias DP; Crestani CC; Martins-Pinge MC
    Life Sci; 2015 Apr; 127():82-9. PubMed ID: 25744393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysautonomias in Parkinson's disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra.
    Ariza D; Sisdeli L; Crestani CC; Fazan R; Martins-Pinge MC
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(3):H250-7. PubMed ID: 25416189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise.
    de Jager L; Amorim EDT; Lucchetti BFC; Lopes FNC; Crestani CC; Pinge-Filho P; Martins-Pinge MC
    Life Sci; 2018 Jul; 204():78-86. PubMed ID: 29746848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
    Boulamery A; Simon N; Vidal J; Bruguerolle B
    Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular evaluation of female rats with 6-OHDA-induced parkinsonism: Possible protection by ovarian hormones and participation of nitric oxide.
    de Campos BH; de Jager L; Reginato GS; Pereira RS; Crestani CC; Pinge-Filho P; Martins-Pinge MC
    Life Sci; 2020 Oct; 259():118259. PubMed ID: 32795538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism.
    de Jager L; Vidigal CB; de Campos BH; Reginato GS; Fernandes LM; Ariza D; Higashi-Mckeown CM; Bertozzi MM; Rasquel de Oliveira FS; Verri WA; Ceravolo GS; Crestani CC; Pinge-Filho P; Martins-Pinge MC
    Nitric Oxide; 2023 May; 134-135():49-60. PubMed ID: 37054808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
    Yin LL; Geng XC; Zhu XZ
    Brain Res Bull; 2011 Nov; 86(5-6):367-72. PubMed ID: 21963945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease.
    Issy AC; Padovan-Neto FE; Lazzarini M; Bortolanza M; Del-Bel E
    Life Sci; 2015 Mar; 125():71-8. PubMed ID: 25681528
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ
    Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
    Song L; Kong M; Ma Y; Ba M; Liu Z
    Brain Res; 2009 Jun; 1276():171-9. PubMed ID: 19393228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease.
    Prinz A; Selesnew LM; Liss B; Roeper J; Carlsson T
    Exp Neurol; 2013 Oct; 248():236-45. PubMed ID: 23810738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
    Chao OY; Pum ME; Li JS; Huston JP
    Neuroscience; 2012 Jan; 202():318-25. PubMed ID: 22142899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.
    Abuirmeileh A; Lever R; Kingsbury AE; Lees AJ; Locke IC; Knight RA; Chowdrey HS; Biggs CS; Whitton PS
    Eur J Neurosci; 2007 Jul; 26(2):417-23. PubMed ID: 17650114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate and GABA neurotransmission are increased in paraventricular nucleus of hypothalamus in rats induced to 6-OHDA parkinsonism: Involvement of nNOS.
    Turossi Amorim ED; de Jager L; Martins AB; Rodrigues AT; Cruz Lucchetti BF; Ariza D; Pinge-Filho P; Crestani CC; Uchoa ET; Martins-Pinge MC
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13264. PubMed ID: 30716212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.
    Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M
    Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.